acute tumor lysis syndrome and treatment response in patients treated for refractory chronic lymphocytic leukemia with short-course, high-dose cytosine arabinoside, cisplatin, and etoposide

作者: Robert D. McCroskey , Deane F. Mosher , Cory D. Spencer , Edward Prendergast , Walter L. Longo

DOI: 10.1002/1097-0142(19900715)66:2<246::AID-CNCR2820660209>3.0.CO;2-B

关键词:

摘要: Acute tumor lysis syndrome resulting from rapid neoplastic cell after chemotherapy is an unusual event, generally seen in histological aggressive lymphatic tumors. The authors saw four patients who developed acute when treated for advanced-stage, refractory chronic lymphocytic leukemia (CLL) with initial cycle of cytosine arabinoside (Ara-C) 2 g/m2 every 12 hours x 4, cisplatin 35 mg/m2 24 2, and etoposide 100 (ACE). With hydration, urine alkalinization, forced diuresis, high-dose allopurinol, was not three subsequent cases CLL ACE. Of a total eight treated, seven had marked reductions lymphocyte counts the first course patients, are alive: one complete remission greater than years, partial cycles ACE, Richter's transformation to large lymphoma. remaining died ACE chemotherapy, as direct complication pancytopenia, others complications severe pancytopenia general debilitation. Therefore, appears cause dissolution cells CLL, appropriate management infectious may have favorable impact on survival advanced CLL.

参考文章(22)
Margaret A. Shipp, Ronald C. Takvorian, George P. Canellos, High-dose cytosine arabinoside The American Journal of Medicine. ,vol. 77, pp. 845- 850 ,(1984) , 10.1016/0002-9343(84)90522-9
J. L. Binet, A. Auquier, G. Dighiero, C. Chastang, H. Piguet, J. Goasguen, G. Vaugier, G. Potron, P. Colona, F. Oberling, M. Thomas, G. Tchernia, C. Jacquillat, P. Boivin, C. Lesty, M. T. Duault, M. Monconduit, S. Belabbes, F. Gremy, A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis Cancer. ,vol. 48, pp. 198- 206 ,(1981) , 10.1002/1097-0142(19810701)48:1<198::AID-CNCR2820480131>3.0.CO;2-V
Lawrence F. Cohen, James E. Balow, Ian T. Magrath, David G. Poplack, John L. Ziegler, Acute tumor lysis syndrome The American Journal of Medicine. ,vol. 68, pp. 486- 491 ,(1980) , 10.1016/0002-9343(80)90286-7
I.R. Judson, E. Wiltshaw, Cis-dichlorodiammineplatinum (cis-platinum) and etoposide (VP-16) in malignant lymphoma--an effective salvage regimen. Cancer Chemotherapy and Pharmacology. ,vol. 14, pp. 258- 261 ,(1985) , 10.1007/BF00258129
Mark E. Stark, Morgan C. D. Dyer, Craig J. Coonley, Fatal acute tumor lysis syndrome with metastatic breast carcinoma. Cancer. ,vol. 60, pp. 762- 764 ,(1987) , 10.1002/1097-0142(19870815)60:4<762::AID-CNCR2820600409>3.0.CO;2-P
D. S. Ettinger, Hyperphosphatemia, hypocalcemia, and transient renal failure. Results of cytotoxic treatment of acute lymphoblastic leukemia JAMA: The Journal of the American Medical Association. ,vol. 239, pp. 2472- 2474 ,(1978) , 10.1001/JAMA.239.23.2472
Ralph V. Boccia, Dan L. Longo, Michael L. Lieber, Elaine S. Jaffe, Richard I. Fisher, Multiple recurrences of acute tumor lysis syndrome in an indolent non-hodgkin's lymphoma Cancer. ,vol. 56, pp. 2295- 2297 ,(1985) , 10.1002/1097-0142(19851101)56:9<2295::AID-CNCR2820560926>3.0.CO;2-X
BRUCE M. MORSE, SANFORD J. SHATTIL, Metabolic complications of aggressive therapy of chronic lymphocytic leukemia. The American Journal of the Medical Sciences. ,vol. 267, pp. 311- 314 ,(1974) , 10.1097/00000441-197405000-00007